Matthew C. Foster, MD | Authors

The Limitations and Promise of Immunotherapy With Chimeric Antigen–Modified T Cells

October 15, 2016

Identification of effective lymphodepletion strategies, optimization of patient selection, and management of novel toxicities remain challenges in the growing field of cellular immunotherapy.